{"id":"W3004063334","doi":"10.1158/1078-0432.ccr-19-1945","title":"Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical Trial","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Institutes of Health Research; National Institutes of Health; Academy of Finland; Mayo Clinic; Breast Cancer Research Foundation; Syöpäjärjestöt; Canadian Cancer Society","keywords":"Capecitabine; Medicine; Oncology; Internal medicine; Hazard ratio; Triple-negative breast cancer; Taxane; Breast cancer; Adjuvant; Proportional hazards model; Cancer; Confidence interval; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003546568,0.0002797303,0.0006656318,0.00008663288,0.0001552778,0.00004386978,0.0007084791,0.0003622177,0.0001150751],"category_scores_gemma":[0.002251435,0.0002019003,0.0003666117,0.0006215477,0.000851171,0.0000143847,0.000360163,0.0008945129,0.000009049587],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001708401,"about_ca_system_score_gemma":0.0007663329,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003488538,"about_ca_topic_score_gemma":0.01010902,"domain_scores_codex":[0.9952933,0.001069998,0.001142574,0.001154116,0.0005600679,0.0007799633],"domain_scores_gemma":[0.9969662,0.001760798,0.0001862982,0.0004702257,0.0003705034,0.0002459245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3281113,0.001543027,0.5925778,0.0001042227,0.0008608995,0.00004752594,0.001305724,0.0001432004,0.0001923305,0.00007590962,0.01476538,0.06027266],"study_design_scores_gemma":[0.07978147,0.003836368,0.9048693,0.00009246985,0.00006691329,0.000001319366,0.001093997,0.0003831356,0.0002727223,0.0001830936,0.009099114,0.0003200611],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9695216,0.002089867,0.00004125031,0.02156567,0.0006599632,0.003302988,0.002549809,0.00001322902,0.0002555832],"genre_scores_gemma":[0.9885449,0.003954888,0.00007126975,0.001118444,0.002740709,0.003290134,0.0000632234,0.00004366989,0.0001727969],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3122915,"threshold_uncertainty_score":0.8233253,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2039480375743586,"score_gpt":0.5027236238608903,"score_spread":0.2987755862865317,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}